![1.jpg 1.jpg](/SupplyImg/2023-12-06/6383747908138624857437538.jpg)
CD28產(chǎn)品信息
英文名稱:T-cell-specific surface glycoprotein CD28
中文名稱:T細(xì)胞特異性表面糖蛋白CD28
靶點(diǎn)別稱:CD28,CD28 Antigen,T-Cell-Specific Surface Glycoprotein CD28,CD28 Antigen (Tp44),Tp44,CD28 Antigens,CD28 Molecule,T-Cell-Specific Surface Glycoprotein
物種:Human / Mouse / Cynomolgus / Rat
屬性:Protein / Antibody / Kits / Antibody Licensing
標(biāo)記:Biotin-labeled / Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.
![2.jpg 2.jpg](/SupplyImg/2023-12-06/6383747909052877143029365.jpg)
CD28分子背景
T細(xì)胞特異性表面糖蛋白CD28也稱為TP44,是一種單程I型膜蛋白,含有一個(gè)Ig樣V型(免疫球蛋白樣)結(jié)構(gòu)域。是T細(xì)胞上表達(dá)的提供T細(xì)胞活化所需的共刺激信號(hào)的分子之一。CD28是CD80(B7.1)和CD86(B7.2)的受體。當(dāng)被Toll樣受體配體激活時(shí),CD80在抗原呈遞細(xì)胞(APCs)中的表達(dá)上調(diào)??乖蔬f細(xì)胞上的CD86表達(dá)是組成型的。CD28是唯一在幼稚T細(xì)胞上組成型表達(dá)的B7受體。
CD28產(chǎn)品用戶評價(jià)
![3.jpg 3.jpg](/SupplyImg/2023-12-06/6383747910299948474218075.jpg)
關(guān)鍵字: CD28;CD28蛋白;CD28抗體;糖蛋白CD28;CD28重組蛋白;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。